Smoking and alanine aminotransferase levels in hepatitis C virus infection - Implications for prevention of hepatitis C virus progression

被引:52
作者
Wang, CS
Wang, ST
Chang, TT
Yao, WJ
Chou, P [1 ]
机构
[1] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Dept Nucl Med, Tainan 70101, Taiwan
[4] Natl Cheng Kung Univ, Inst Publ Hlth, Div Gastroenterol, Dept Internal Med, Tainan 70101, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Inst Publ Hlth, Dept Med, Tainan 70101, Taiwan
关键词
D O I
10.1001/archinte.162.7.811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Alcohol consumption is a well-known risk factor for elevated ALT levels, but the role of cigarette smoking is unclear. Methods: We collected a cross-sectional sample of 6095 inhabitants 35 years or older in a community with hyperendemic hepatitis B and C virus infections. We assayed levels of serum alanine aminotransferase (ALT), hepatitis B surface antigen (HBsAg), and anti-hepatitis C virus antibody (anti-HCV). Multivariate logistic regression was performed to determine the factors for elevated ALT levels (greater than or equal to40 U/L) among people with different hepatitis infection statuses. Results: Prevalence of elevated ALT levels in individuals who were seronegative for both infections or seropositive for HBsAg or anti-HCV was 3.9%, 11.1%, and 30.8%, respectively. Subjects with elevated ALT levels were more likely to be seropositive for anti-HCV, male, and seropositive for HBsAg; to drink alcohol; to smoke; and to have undergone blood transfusion (P<.05). An association was found between elevated ALT levels and the consumption of cigarettes and alcohol among anti-HCV-seropositive subjects. In multivariate logistic analyses, alcohol consumption (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.2-4.1) and smoking (OR, 1.8; 95% CI, 1.1-2.7) were significantly associated with elevated ALT levels among, anti-HCV-seropositive subjects, but no such association was found among HBsAg-seropositive subjects. The odds of elevated ALT levels were 7 times higher (95% CI, 2.7-1-8.8) for the anti-HCV-seropositive patients who smoked 1 or more packs of cigarettes per day and frequently drank alcohol than for those who did not. Conclusions: Smoking and alcohol consumption are independently associated with elevated ALT levels among anti-HCV-seropositive individuals but not among HBsAg-seropositive individuals. Patients who are seropositive for anti-HCV are strongly advised not to smoke and drink alcohol to reduce the possible risk for aggravating the liver dysfunction.
引用
收藏
页码:811 / 815
页数:5
相关论文
共 24 条
[1]  
Akriviadis EA, 1998, BRIT J SURG, V85, P1319
[2]  
[Anonymous], 1997, HEPATOLOGY, V26, pS2
[3]  
[Anonymous], STAT REF MAN REL 3
[4]   Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B [J].
Chien, RN ;
Liaw, YF ;
Atkins, M .
HEPATOLOGY, 1999, 30 (03) :770-774
[5]   Hepatitis C and alcohol [J].
Degos, F .
JOURNAL OF HEPATOLOGY, 1999, 31 :113-118
[6]   The impact of smoking, alcohol consumption, and physical activity on use of hospital services [J].
Haapanen-Niemi, N ;
Miilunpalo, S ;
Vuori, I ;
Pasanen, M ;
Oja, P .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (05) :691-698
[7]   Hepatitis C: The clinical spectrum of disease [J].
Hoofnagle, JH .
HEPATOLOGY, 1997, 26 (03) :S15-S20
[8]   Therapy of hepatitis C: Overview [J].
Lindsay, KL .
HEPATOLOGY, 1997, 26 (03) :S71-S77
[9]   Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men [J].
Makimoto, K ;
Higuchi, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (01) :30-34
[10]   Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity [J].
Mathurin, P ;
Moussalli, J ;
Cadranel, JF ;
Thibault, V ;
Charlotte, F ;
Dumouchel, P ;
Cazier, A ;
Huraux, JM ;
Devergie, B ;
Vidaud, M ;
Opolon, P ;
Poynard, T .
HEPATOLOGY, 1998, 27 (03) :868-872